Search

43 results for “Pharmacovigilance”

• Review ArticleOpen Access

  Pharmacovigilance in Asia

  Pipasha Biswas

  Vol. 4 · Issue Supplement 1 · pp. S7–S8

  https://doi.org/10.4103/0976-500X.120941
  Full text ↗PDF

• Review ArticleOpen Access

  Pharmacovigilance in Italy: An overview

  Carmela Mazzitello, Stefania Esposito, Adele E. De Francesco, Annalisa Capuano, Emilio Russo, Giovambattista De Sarro

  Vol. 4 · Issue Supplement 1 · pp. S20–S21

  https://doi.org/10.4103/0976-500X.120942
  Full text ↗PDF

• WebwiseOpen Access

  The pharmacovigilance toolkit

  P. Ravi Shankar

  Vol. 4 · Issue 4 · pp. 307–308

  Full text ↗PDF

• CommentaryOpen Access

  Pharmacovigilance and the Italian Medicines Agency

  Giuseppe Pimpinella, Loriana Tartaglia

  Vol. 4 · Issue Supplement 1 · pp. 4–6

  https://doi.org/10.4103/0976-500X.120940
  Full text ↗PDF

• CommentaryOpen Access

  Informatics applied to pharmacovigilance: Future perspectives

  Michele Menniti, Annamaria Menniti, Marinella Patanè, Stefania Esposito, Chiara Giofrè, Rossana Aiello, Emilio Russo

  Vol. 4 · Issue 1 · pp. S43–S44

  https://doi.org/10.4103/0976-500X.120950
  Full text ↗PDF

• MethodsOpen Access

  Starting a pharmacovigilance center: Actions for implementation

  Mrinmoy Chakrabarty, Vijay Thawani

  Vol. 2 · Issue 4 · pp. 295–299

  https://doi.org/10.4103/0976-500X.85945
  Full text ↗PDF

• EditorialOpen Access

  Pharmacovigilance in Calabria (Italy): Local experiences resonate international relevance

  Emilio Russo, Giovambattista De Sarro

  Vol. 4 · Issue Supplement 1 · pp. 1–3

  https://doi.org/10.4103/0976-500X.120938
  Full text ↗PDF

• CorrespondenceOpen Access

  An adverse drug reaction clinic: Breathing fresh life into the pharmacovigilance programme

  Dick B. S. Brashier, Sushil Sharma

  Vol. 3 · Issue 1 · pp. 74–75

  https://doi.org/10.4103/0976-500X.92501
  Full text ↗PDF

• Short CommunicationOpen Access

  Pharmacovigilance Consideration for Ayurvedic Medicines in Pediatric Practice: Developing Protocols for Documenting Clinical Safety

  Dinesh Karayil Subramanian, Geethu Balakrishnan

  Vol. 15 · Issue 4 · pp. 442–448

  https://doi.org/10.1177/0976500X241276311
  Full text ↗PDF

• News and ViewsOpen Access

  The association of oral contraceptive pills with increase in intraocular pressure: Time for pharmacovigilance to step in

  Sangeeta Bhanwra, Kaza Ahluwalia

  Vol. 6 · Issue 1 · pp. 51–2

  https://doi.org/10.4103/0976-500X.149150
  Full text ↗PDF

• Research LetterOpen Access

  Pharmacovigilance and adverse drug reaction reporting perspectives among interns and postgraduates of a teaching hospital

  Raghava Sharma, Adithi Kellarai

  Vol. 5 · Issue 4 · pp. 248–250

  https://doi.org/10.4103/0976-500X.142436
  Full text ↗PDF

• Research LetterOpen Access

  Evaluation of inter-rater agreement between three causality assessment methods used in pharmacovigilance

  Saket J. Thaker, Rahul S. Sinha, Nithya J. Gogtay, Urmila M. Thatte

  Vol. 7 · Issue 1 · pp. 31–3

  https://doi.org/10.4103/0976-500X.179361
  Full text ↗PDF

• Research LetterOpen Access

  Levocetirizine-induced Psychiatric Disorders in a Pediatric Patient: A Case Report and a Pharmacovigilance Database Analysis

  Carla Carnovale, Simone Russo, Gigliola Biondelli, Marta Gentili, Marco Pozzi, Stefania Antoniazzi, Sonia Radice, Emilio Clementi

  Vol. 8 · Issue 2 · pp. 74–6

  https://doi.org/10.4103/jpp.JPP_14_17
  Full text ↗PDF

• Case ReviewOpen Access

  Vertigo/dizziness as a Drugs’ adverse reaction

  Serafina Chimirri, Rossana Aiello, Carmela Mazzitello, Laura Mumoli, Caterina Palleria, Mariolina Altomonte, Rita Citraro, Giovambattista Sarro

  Vol. 4 · Issue Supplement 1 · pp. S104–S105

  https://doi.org/10.4103/0976-500X.120969
  Full text ↗PDF

• Review ArticleOpen Access

  Clinical and economic burden of adverse drug reactions

  Janet Sultana, Paola Cutroneo, Gianluca Trifirò

  Vol. 4 · Issue 1 · pp. S73–S74

  https://doi.org/10.4103/0976-500X.120957
  Full text ↗PDF

• Case ReviewOpen Access

  The safety of ketoprofen in different ages

  Claudia Carbone, Pierandrea Rende, Pasquale Comberiati, Domenico Carnovale, Maria Mammì, Giovambattista De Sarro

  Vol. 4 · Issue Supplement 1 · pp. S99–S100

  https://doi.org/10.4103/0976-500X.120967
  Full text ↗PDF

• Research ArticleOpen Access

  A Prospective, Observational Study of the Spontaneous Reporting Patterns of Adverse Drug Reactions in a Tertiary Care Teaching Hospital

  Santhosh Kumar Raju, Geetha S., Shobha Kamble

  Vol. 13 · Issue 3 · pp. 272–277

  https://doi.org/10.1177/0976500X221130841
  Full text ↗PDF

• CommentaryOpen Access

  Limitations and obstacles of the spontaneous adverse drugs reactions reporting: Two “challenging” case reports

  Caterina Palleria, Christian Leporini, Serafina Chimirri, Giuseppina Marrazzo, Sabrina Sacchetta, Lucrezia Bruno, Rosaria M. Lista, Orietta Staltari, Antonio Scuteri, Francesca Scicchitano, Emilio Russo

  Vol. 4 · pp. S66–S67

  https://doi.org/10.4103/0976-500X.120955
  Full text ↗PDF

• Research LetterOpen Access

  Comparison of agreement and rational uses of the WHO and Naranjo adverse event causality assessment tools

  Niti Mittal, Mahesh C. Gupta

  Vol. 6 · Issue 2 · pp. 91–93

  https://doi.org/10.4103/0976-500X.155486
  Full text ↗PDF

• Original PaperOpen Access

  Adverse drug reactions of nonsteroidal anti-inflammatory drugs in orthopedic patients

  Alpa Pragnesh Gor, Miti Saksena

  Vol. 2 · Issue 1 · pp. 26–27

  https://doi.org/10.4103/0976-500X.77104
  Full text ↗PDF